Salesforce, Inc.
In the published model solve dated 2026-Q2, anchored at $256.48, Salesforce, Inc. (CRM) is priced for +22.6% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. The narrative was composed July 25, 2026 from SEC EDGAR filings.
• Agentforce and Data 360 annual recurring revenue reached nearly 3.4 billion dollars in the April 2026 quarter, up more than 200% year over year, with Agentforce itself at 1.2 billion, which is the clearest evidence yet that the AI transition is being sold rather than suffered [Source: Q1 FY2027 earnings release, May 27, 2026]. • The balance sheet changed character this year: roughly 25 billion dollars was borrowed to fund an accelerated share repurchase, and quarterly interest expense went fro
Is CRM overvalued? See what's priced in →
2,609 institutional managers reported holding CRM in 13F filings for the quarter ended 2026-03-31. Together they hold about 77% of the company; the top 10 hold 36%. 186 opened new positions that quarter. Held by Vanguard Group, BlackRock, State Street, among others. On the short side, 59.1M shares were sold short as of the 2026-06-15 count, about 7% of shares outstanding (3.8 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
CRM has cut its share count 7% over the past five years, spending $59.41B on repurchases. It pays a dividend, and has for 2 years running. Cash returned over the past three years: $3.49B in dividends and $53.36B in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at CRM over the trailing three years: 2024: 2 buys totaling $100.30M; 2025: 5 buys totaling $27.88M; 2026: 3 buys totaling $1.00M. 28 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
CRM's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-09-01 | +4.5% | -6.3% |
| 2023-12-01 | +12.0% | +9.9% |
| 2024-03-07 | +3.1% | -9.0% |
| 2024-05-31 | -19.2% | +4.1% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
CRM's latest 8-K filings: 2026-08-26 (items 2.02, 9.01); 2026-08-05 (items 5.02); 2026-06-02 (items 5.02); 2026-06-01 (items 5.02, 9.01); 2026-05-27 (items 2.02, 9.01).
Item codes are the SEC's own classification of what each report discloses. Dates link to the filing on EDGAR. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: July 25, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.